Oncology Central

EACR congress: key talks and highlights

We recently attended the 25th Biennial Congress of the European Association for Cancer Research (EACR, 30th June – 3rd July, Amsterdam, Netherlands) and had the honor of speaking with the EACR President and Conference Chair Anton Berns (Netherlands Cancer Institute, Amsterdam). In this conference report, find out Anton key talks and highlights from the congress.

One of the key presentations of the congress came from Charles Swanton from The Francis Crick Institute (London, UK). His talk explored the TRACERx (TRAcking Cancer Evolution through therapy (Rx) lung study and cancer evolution. The TRACERx study aims to uncover mechanisms of cancer evolution by analyzing the intratumour heterogeneity in lung tumors from approximately 850 patients and tracks its evolutionary trajectory from diagnosis through to relapse. It is hoped that the study will enable researchers to define how intratumour heterogeneity impacts upon cancer immunity throughout tumor evolution and therapy.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.